Search Results 1431-1440 of 16195 for chemoprevention
A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in ...
ROCHESTER, Minn. — For many doctors and researchers, immunotherapy that uses someone's own immune system to target and attack cancer cells is the next and best ...
Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.
About this study. This phase II trial studies how well surgery works in preventing ovarian cancer in patients with genetic mutations at risk of ovarian ...
He has pursued a “one-shot cancer cure” at Mayo Clinic, where he started the Department of Molecular Medicine, built an oncolytic virotherapy program and ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and compare with ...
A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The Developmental Research Program in the Mayo Clinic Multiple Myeloma SPORE supports innovative, scientifically sound research projects in any area related ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.